The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

NCT07459283 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Maligant Solid Tumor
Head & Neck Cancer
Thyroid Cancer
Lung Cancer - Non Small Cell Squamous
Breast Cancer
Sarcoma

Interventions

DRUG: INN805

Sponsor

FindCure Biosciences (ZhongShan) Co., Ltd.

Collaborators

[object Object]